MEDI-PEEL , , ( B3), , () 50 , , , , 8809941820645 Water, Glycereth-26, Methylpropanediol, Butylene Glycol, Glycerin, 1,2-Hexanediol, Niacinamide, Neopentyl Glycol Diheptanoate, Polyglyceryl-3 Methylglucose Distearate, PEG-240/HDI Copolymer Bis-Decyltetradeceth-20 Ether, Caprylic/Capric Triglyceride, Phenyl Trimethicone, Glyceryl Stearate, Cyclopentasiloxane, PEG-60 Hydrogenated Castor Oil, Cyclohexasiloxane, Ammonium Acryloyldimethyltaurate/VP Copolymer, C12-16 Alcohols, Glutathione(990 ppm), Palmitic Acid, Hydrogenated Lecithin, Ethylhexylglycerin, Adenosine, Diospyros Kaki Fruit Extract, Chloramine T, Sodium Bicarbonate, Sodium Carbonate, Propanediol, Sodium Hyaluronate Crosspolymer (50 ppm), Prunella Vulgaris Extract, Fucus Vesiculosus Extract, Hydrolyzed Glycosaminoglycans(30 ppm), Glycine, Sodium Hyaluronate (15 ppm), Serine, Glutamic Acid, Potassium Laurate, Benzyl Glycol, Aspartic Acid, Leucine, BHT, Alanine, Lysine, Arginine, Tyrosine, Phenylalanine, Threonine, Proline, Valine, Isoleucine, Hydrolyzed Hyaluronic Acid(2.5 ppm), Histidine, Methionine, Cysteine, Ectoin, Ceramide NP, Water(Carbonated Water), Panthenol, Glyceryl Glucoside, Xylitylglucoside, Anhydroxylitol, Xylitol, Hyaluronic Acid(0.05 ppm), Hydrolyzed Collagen, Polyglyceryl-10 Laurate, Polyglyceryl-10 Stearate, Raspberry Ketone, Pantolactone, Sodium Ascorbyl Phosphate, Tripeptide-1, Hexapeptide-9, Acetyl Tetrapeptide-5, Copper Tripeptide-1, Biotin, Acetyl Tetrapeptide-2, Palmitoyl Pentapeptide-4, Hexapeptide-11, Pyridoxine, Folic Acid, Acetyl Hexapeptide-8, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-5, Tocopherol, Cyanocobalamin, Alanine/ Histidine/ Lysine Polypeptide Copper HCl, Tripeptide-32, Linoleic Acid, Riboflavin, Beta-Carotene, Inositol, Thiamine HCl, Disodium EDTA, Fragrance
Canado GMA et al
Monomeric C-reactive protein a feature of inflammatory disease associated with cardiovascular pathophysiological complications
Some evidence suggests GHK-Cu may have anti-cancer properties, making it potentially more suitable for higher-risk individuals
Skin Laxity During Rapid Weight Loss One of the most common concerns among patients on GLP-1 therapies is skin quality
5.3 Anti-inflammatory and antioxidant activities Chronic inflammation contributes to the development of several diseases, such as IBD (Rubin et al., 2012
